• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

BerGenBio

Selective AXL inhibitors

  • About BerGenBio
    • About BerGenBio
    • Management Team
    • Board of Directors
    • Partners
  • Pipeline
    • Pipeline overview
    • bemcentinib | NSCLC
    • bemcentinib | COVID-19
    • bemcentinib | Melanoma
    • bemcentinib | AML
    • BGB149
    • BGB601
    • Discovery
    • Publications
    • Expanded access policy
  • Media Centre
    • News
    • Events
    • COVID-19 Media Pack
    • Media Contacts
  • Investors
    • Share Information
    • Largest Shareholders
    • Stock Exchange Notices
    • Presentations
    • Financial Reports
    • Financial Calendar
    • Analysts
    • General Meetings
    • Corporate Governance
    • IR Contacts
  • Careers
  • Contact
Home  /  Events  /  BERGENBIO ASA: Invitation to FOURTH quarter 2020 results

BERGENBIO ASA: Invitation to FOURTH quarter 2020 results

Feb 10, 2021

Share This Post

Add to Calendar 02/10/2021 9:00 am Europe/Oslo BERGENBIO ASA: Invitation to FOURTH quarter 2020 results For more information visit: https://www.bergenbio.com/bergenbio-asa-invitation-to-fourth-quarter-2020-results/

A webcast presentation by BerGenBio’s senior management team will take place Wednesday 10th February 2021 at 10:00 am CET.

The live webcast link will be available at www.bergenbio.com in the Investors/Financial Reports section. A recording will be available shortly after the webcast has finished.

The fourth quarter report and presentation will be available on the Company’s website in the Investors/Financial Reports section from 7:00 am CET the same day.

Webcast link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210210_5

Dial-in numbers: 

NO: +47-21-956342  

SE: +46-4-0682-0620  

DK: +45 78768490  

UK: +44-203-7696819  

US: +1 646-787-0157  

Pin: 712491  

Primary Sidebar

  • Media Centre
  • News
  • Events
  • COVID-19 Media Pack
  • Media Contacts

News Subscription

Please remember to confirm your email by clicking on the link provided in the subscription confirmation email.

We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.

Footer

Key Information

  • Pipeline
  • Investors
  • News
  • Presentations
  • Management Team

Useful Information

  • Privacy Policy
  • Terms of Use
  • Job Applicant Privacy Notice
  • Site Map

Get In Touch

BerGenBio ASA
Company registration number 992 219 688

Jonas Lies vei 91, 5009 Bergen, Norway

www.bergenbio.com

+ 47 559 61 159

Copyright © 2017 BerGenBio ASA. All right reserved. Designed by Utopian Designs